<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://powerbase.info/index.php?action=history&amp;feed=atom&amp;title=Pharma%3A_UK_libel_law</id>
	<title>Pharma: UK libel law - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://powerbase.info/index.php?action=history&amp;feed=atom&amp;title=Pharma%3A_UK_libel_law"/>
	<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;action=history"/>
	<updated>2026-07-05T07:12:14Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.35.14</generator>
	<entry>
		<id>https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108191&amp;oldid=prev</id>
		<title>Claire Robinson at 16:23, 19 February 2010</title>
		<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108191&amp;oldid=prev"/>
		<updated>2010-02-19T16:23:15Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left diff-editfont-monospace&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 16:23, 19 February 2010&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Template:Pharma_Portal_badge}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Template:Pharma_Portal_badge}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary [[General Electric]], was launching a 'counterclaim for libel.' &amp;lt;ref&amp;gt; Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at Copenhagen University Hospital have developed nephrogenic systemic fibrosis (NSF). &amp;lt;ref&amp;gt;Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomsen counter-sued the company for defamation after it called him a liar in a press release. '''GE Healthcare''' subsequently dropped the libel action claiming it 'did not mean to stifle academic debate'.&amp;lt;ref&amp;gt;Leigh, D. ''The Guardian.'' 18 February 2010.[http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomson released a statement claiming:&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;of &lt;/ins&gt;[[General Electric]], was launching a 'counterclaim for libel.' &amp;lt;ref&amp;gt; Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at Copenhagen University Hospital have developed nephrogenic systemic fibrosis (NSF). &amp;lt;ref&amp;gt;Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomsen counter-sued the company for defamation after it called him a liar in a press release. '''GE Healthcare''' subsequently dropped the libel action claiming it 'did not mean to stifle academic debate'.&amp;lt;ref&amp;gt;Leigh, D. ''The Guardian.'' 18 February 2010.[http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomson released a statement claiming:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D.''The Guardian.'' 18 February 2010. [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D.''The Guardian.'' 18 February 2010. [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Claire Robinson</name></author>
	</entry>
	<entry>
		<id>https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108172&amp;oldid=prev</id>
		<title>Claire Robinson at 12:20, 19 February 2010</title>
		<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108172&amp;oldid=prev"/>
		<updated>2010-02-19T12:20:30Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left diff-editfont-monospace&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 12:20, 19 February 2010&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l5&quot; &gt;Line 5:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 5:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D.''The Guardian.'' 18 February 2010. [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D.''The Guardian.'' 18 February 2010. [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;GE Healthcare in the financial year 2007-8 was a funder of [[Sense About Science]]&amp;lt;ref&amp;gt;Sense About Science Financial Statement Year Ended 5 April 2008, available [http://www.spinprofiles.org/index.php/Image:Sas2008.pdf here]&amp;lt;/ref&amp;gt;. SAS has run a high-profile campaign against libel laws in science (Keep Libel Laws out of Science&amp;lt;ref&amp;gt;[http://www.senseaboutscience.org.uk/index.php/site/project/333/ National Petition for Libel Law Reform], SAS website, accessed 16 Feb 2010&amp;lt;/ref&amp;gt;) in relation to the case of the science writer Simon Singh being sued for libel by the British Chiropractic Association for an article in the Guardian in which he claimed &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;chiropractic was &lt;/del&gt;bogus.&amp;lt;ref&amp;gt;[http://www.newscientist.com/article/mg20227083.000-chiropractic-critic-loses-first-round-in-libel-fight.html Chiropractic critic loses first round in libel fight], New Scientist, Issue 2708, 15 May 2009, accessed 19 Feb 2010&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;GE Healthcare in the financial year 2007-8 was a funder of [[Sense About Science]]&amp;lt;ref&amp;gt;Sense About Science Financial Statement Year Ended 5 April 2008, available [http://www.spinprofiles.org/index.php/Image:Sas2008.pdf here]&amp;lt;/ref&amp;gt;. SAS has run a high-profile campaign against libel laws in science (Keep Libel Laws out of Science&amp;lt;ref&amp;gt;[http://www.senseaboutscience.org.uk/index.php/site/project/333/ National Petition for Libel Law Reform], SAS website, accessed 16 Feb 2010&amp;lt;/ref&amp;gt;) in relation to the case of the science writer Simon Singh being sued for libel by the British Chiropractic Association for an article in the Guardian in which he claimed &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;the BCA promoted &amp;quot;&lt;/ins&gt;bogus&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;&amp;quot; treatments&lt;/ins&gt;.&amp;lt;ref&amp;gt;[http://www.newscientist.com/article/mg20227083.000-chiropractic-critic-loses-first-round-in-libel-fight.html Chiropractic critic loses first round in libel fight], New Scientist, Issue 2708, 15 May 2009, accessed 19 Feb 2010&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Notes==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Notes==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Claire Robinson</name></author>
	</entry>
	<entry>
		<id>https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108171&amp;oldid=prev</id>
		<title>Claire Robinson at 12:19, 19 February 2010</title>
		<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108171&amp;oldid=prev"/>
		<updated>2010-02-19T12:19:56Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left diff-editfont-monospace&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 12:19, 19 February 2010&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l5&quot; &gt;Line 5:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 5:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D.''The Guardian.'' 18 February 2010. [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D.''The Guardian.'' 18 February 2010. [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;GE Healthcare in the financial year 2007-8 was a funder of [[Sense About Science]]&amp;lt;ref&amp;gt;Sense About Science Financial Statement Year Ended 5 April 2008, available [http://www.spinprofiles.org/index.php/Image:Sas2008.pdf here]&amp;lt;/ref&amp;gt;. SAS has run a high-profile campaign against libel laws in science (Keep Libel Laws out of Science&amp;lt;ref&amp;gt;[http://www.senseaboutscience.org.uk/index.php/site/project/333/ National Petition for Libel Law Reform], SAS website, accessed 16 Feb 2010&amp;lt;/ref&amp;gt;) in relation to the case of the science writer Simon Singh being sued for libel by the British Chiropractic Association for an article in the Guardian in which he claimed chiropractic was bogus.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;GE Healthcare in the financial year 2007-8 was a funder of [[Sense About Science]]&amp;lt;ref&amp;gt;Sense About Science Financial Statement Year Ended 5 April 2008, available [http://www.spinprofiles.org/index.php/Image:Sas2008.pdf here]&amp;lt;/ref&amp;gt;. SAS has run a high-profile campaign against libel laws in science (Keep Libel Laws out of Science&amp;lt;ref&amp;gt;[http://www.senseaboutscience.org.uk/index.php/site/project/333/ National Petition for Libel Law Reform], SAS website, accessed 16 Feb 2010&amp;lt;/ref&amp;gt;) in relation to the case of the science writer Simon Singh being sued for libel by the British Chiropractic Association for an article in the Guardian in which he claimed chiropractic was bogus.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;&amp;lt;ref&amp;gt;[http://www.newscientist.com/article/mg20227083.000-chiropractic-critic-loses-first-round-in-libel-fight.html Chiropractic critic loses first round in libel fight], New Scientist, Issue 2708, 15 May 2009, accessed 19 Feb 2010&amp;lt;/ref&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Notes==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Notes==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Claire Robinson</name></author>
	</entry>
	<entry>
		<id>https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108170&amp;oldid=prev</id>
		<title>Claire Robinson at 12:17, 19 February 2010</title>
		<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108170&amp;oldid=prev"/>
		<updated>2010-02-19T12:17:58Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left diff-editfont-monospace&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 12:17, 19 February 2010&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l4&quot; &gt;Line 4:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 4:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D.''The Guardian.'' 18 February 2010. [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D.''The Guardian.'' 18 February 2010. [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;GE Healthcare in the financial year 2007-8 was a funder of [[Sense About Science]]&amp;lt;ref&amp;gt;Sense About Science Financial Statement Year Ended 5 April 2008, available [http://www.spinprofiles.org/index.php/Image:Sas2008.pdf here]&amp;lt;/ref&amp;gt;. SAS has run a high-profile campaign against libel laws in science (Keep Libel Laws out of Science&amp;lt;ref&amp;gt;[http://www.senseaboutscience.org.uk/index.php/site/project/333/ National Petition for Libel Law Reform], SAS website, accessed 16 Feb 2010&amp;lt;/ref&amp;gt;) in relation to the case of the science writer Simon Singh being sued for libel by the British Chiropractic Association for an article in the Guardian in which he claimed chiropractic was bogus.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Notes==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Notes==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Claire Robinson</name></author>
	</entry>
	<entry>
		<id>https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108168&amp;oldid=prev</id>
		<title>Claire Robinson at 12:12, 19 February 2010</title>
		<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108168&amp;oldid=prev"/>
		<updated>2010-02-19T12:12:56Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left diff-editfont-monospace&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 12:12, 19 February 2010&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Template:Pharma_Portal_badge}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Template:Pharma_Portal_badge}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary [[General Electric]], was launching a 'counterclaim for libel.' &amp;lt;ref&amp;gt; Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Copehnhagen &lt;/del&gt;University Hospital have developed nephrogenic systemic fibrosis (NSF). &amp;lt;ref&amp;gt;Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomsen counter-sued the company for defamation after it called him a liar in a press release. '''GE Healthcare''' subsequently dropped the libel action claiming it 'did not mean to stifle academic debate'.&amp;lt;ref&amp;gt;Leigh, D. ''The Guardian.'' 18 February 2010.[http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomson released a statement claiming:&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary [[General Electric]], was launching a 'counterclaim for libel.' &amp;lt;ref&amp;gt; Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Copenhagen &lt;/ins&gt;University Hospital have developed nephrogenic systemic fibrosis (NSF). &amp;lt;ref&amp;gt;Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomsen counter-sued the company for defamation after it called him a liar in a press release. '''GE Healthcare''' subsequently dropped the libel action claiming it 'did not mean to stifle academic debate'.&amp;lt;ref&amp;gt;Leigh, D. ''The Guardian.'' 18 February 2010.[http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomson released a statement claiming:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D.''The Guardian.'' 18 February 2010. [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D.''The Guardian.'' 18 February 2010. [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Claire Robinson</name></author>
	</entry>
	<entry>
		<id>https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108135&amp;oldid=prev</id>
		<title>Marisa de Andrade at 18:40, 18 February 2010</title>
		<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108135&amp;oldid=prev"/>
		<updated>2010-02-18T18:40:29Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left diff-editfont-monospace&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 18:40, 18 February 2010&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Template:Pharma_Portal_badge}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Template:Pharma_Portal_badge}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary [[General Electric]], was launching a 'counterclaim for libel.' &amp;lt;ref&amp;gt; Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at Copehnhagen University Hospital have developed nephrogenic systemic fibrosis (NSF). &amp;lt;ref&amp;gt;Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomsen counter-sued the company for defamation after it called him a liar in a press release. '''GE Healthcare''' subsequently dropped the libel action claiming it 'did not mean to stifle academic debate'.&amp;lt;ref&amp;gt;Leigh, D&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;. 18 February 2010&lt;/del&gt;. ''The Guardian'' [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomson released a statement claiming:&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary [[General Electric]], was launching a 'counterclaim for libel.' &amp;lt;ref&amp;gt; Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at Copehnhagen University Hospital have developed nephrogenic systemic fibrosis (NSF). &amp;lt;ref&amp;gt;Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomsen counter-sued the company for defamation after it called him a liar in a press release. '''GE Healthcare''' subsequently dropped the libel action claiming it 'did not mean to stifle academic debate'.&amp;lt;ref&amp;gt;Leigh, D. ''The Guardian&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;.&lt;/ins&gt;'' &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;18 February 2010.&lt;/ins&gt;[http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomson released a statement claiming:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;. 18 February 2010&lt;/del&gt;. ''The Guardian'' [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D.''The Guardian&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;.&lt;/ins&gt;'' &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;18 February 2010. &lt;/ins&gt;[http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Notes==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Notes==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Marisa de Andrade</name></author>
	</entry>
	<entry>
		<id>https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108134&amp;oldid=prev</id>
		<title>Marisa de Andrade at 18:39, 18 February 2010</title>
		<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108134&amp;oldid=prev"/>
		<updated>2010-02-18T18:39:11Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left diff-editfont-monospace&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 18:39, 18 February 2010&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Template:Pharma_Portal_badge}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Template:Pharma_Portal_badge}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary [[General Electric]], was launching a 'counterclaim for libel.' &amp;lt;ref&amp;gt; Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at Copehnhagen University Hospital have developed nephrogenic systemic fibrosis (NSF). &amp;lt;ref&amp;gt;Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomsen counter-sued the company for defamation after it called him a liar in a press release. '''GE Healthcare''' subsequently dropped the libel action claiming it 'did not mean to stifle academic debate'.&amp;lt;ref&amp;gt;Leigh, D. 18 February 2010. ''The Guardian'' [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist' Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomson released a statement claiming:&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary [[General Electric]], was launching a 'counterclaim for libel.' &amp;lt;ref&amp;gt; Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at Copehnhagen University Hospital have developed nephrogenic systemic fibrosis (NSF). &amp;lt;ref&amp;gt;Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomsen counter-sued the company for defamation after it called him a liar in a press release. '''GE Healthcare''' subsequently dropped the libel action claiming it 'did not mean to stifle academic debate'.&amp;lt;ref&amp;gt;Leigh, D. 18 February 2010. ''The Guardian'' [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;] &lt;/ins&gt;Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomson released a statement claiming:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D. 18 February 2010. ''The Guardian'' [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist' Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D. 18 February 2010. ''The Guardian'' [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;] &lt;/ins&gt;Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Notes==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Notes==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Marisa de Andrade</name></author>
	</entry>
	<entry>
		<id>https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108133&amp;oldid=prev</id>
		<title>Marisa de Andrade at 18:28, 18 February 2010</title>
		<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108133&amp;oldid=prev"/>
		<updated>2010-02-18T18:28:06Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left diff-editfont-monospace&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 18:28, 18 February 2010&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Template:Pharma_Portal_badge}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Template:Pharma_Portal_badge}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary [[General Electric]], was launching a 'counterclaim for libel.' &amp;lt;ref&amp;gt; Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at Copehnhagen University Hospital have developed nephrogenic systemic fibrosis (NSF). &amp;lt;ref&amp;gt;Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomsen &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;is allegedly &lt;/del&gt;counter-&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;suing &lt;/del&gt;the company for defamation after it called him a liar in a press release.  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary [[General Electric]], was launching a 'counterclaim for libel.' &amp;lt;ref&amp;gt; Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at Copehnhagen University Hospital have developed nephrogenic systemic fibrosis (NSF). &amp;lt;ref&amp;gt;Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomsen counter-&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;sued &lt;/ins&gt;the company for defamation after it called him a liar in a press release. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;'''GE Healthcare''' subsequently dropped the libel action claiming it 'did not mean to stifle academic debate'.&amp;lt;ref&amp;gt;Leigh, D. 18 February 2010. ''The Guardian'' [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist' Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomson released a statement claiming:&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;:&amp;quot;I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF.&amp;quot;&amp;lt;ref&amp;gt;Leigh, D. 18 February 2010. ''The Guardian'' [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist' Accessed 18 February 2010.&amp;lt;/ref&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Notes==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Notes==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Marisa de Andrade</name></author>
	</entry>
	<entry>
		<id>https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108132&amp;oldid=prev</id>
		<title>Marisa de Andrade: New page: {{Template:Pharma_Portal_badge}}  In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by GE Healthcare, a subsidiary General Electric, was ...</title>
		<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Pharma:_UK_libel_law&amp;diff=108132&amp;oldid=prev"/>
		<updated>2010-02-18T18:20:09Z</updated>

		<summary type="html">&lt;p&gt;New page: {{Template:Pharma_Portal_badge}}  In February 2010, &amp;#039;&amp;#039;&amp;#039;The Guardian&amp;#039;&amp;#039;&amp;#039; reported that a Danish radiologist being sued for libel by &lt;a href=&quot;/index.php/GE_Healthcare&quot; title=&quot;GE Healthcare&quot;&gt;GE Healthcare&lt;/a&gt;, a subsidiary &lt;a href=&quot;/index.php/General_Electric&quot; title=&quot;General Electric&quot;&gt;General Electric&lt;/a&gt;, was ...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Template:Pharma_Portal_badge}}&lt;br /&gt;
&lt;br /&gt;
In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary [[General Electric]], was launching a 'counterclaim for libel.' &amp;lt;ref&amp;gt; Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at Copehnhagen University Hospital have developed nephrogenic systemic fibrosis (NSF). &amp;lt;ref&amp;gt;Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.&amp;lt;/ref&amp;gt; Thomsen is allegedly counter-suing the company for defamation after it called him a liar in a press release. &lt;br /&gt;
&lt;br /&gt;
==Notes==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
[[Category: Pharma]]&lt;br /&gt;
[[Category:Biotech Industry]]&lt;br /&gt;
[[Category:Pharmaceutical Industry]]&lt;/div&gt;</summary>
		<author><name>Marisa de Andrade</name></author>
	</entry>
</feed>